BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

496 related articles for article (PubMed ID: 33271119)

  • 41. Dendritic cells loaded with mRNA encoding full-length tumor antigens prime CD4+ and CD8+ T cells in melanoma patients.
    Van Nuffel AM; Benteyn D; Wilgenhof S; Pierret L; Corthals J; Heirman C; van der Bruggen P; Coulie PG; Neyns B; Thielemans K; Bonehill A
    Mol Ther; 2012 May; 20(5):1063-74. PubMed ID: 22371843
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Soluble HLA-G inhibits myeloid dendritic cell function in HIV-1 infection by interacting with leukocyte immunoglobulin-like receptor B2.
    Huang J; Burke P; Yang Y; Seiss K; Beamon J; Cung T; Toth I; Pereyra F; Lichterfeld M; Yu XG
    J Virol; 2010 Oct; 84(20):10784-91. PubMed ID: 20702625
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Single T cell receptor-mediated recognition of an identical HIV-derived peptide presented by multiple HLA class I molecules.
    Ueno T; Tomiyama H; Takiguchi M
    J Immunol; 2002 Nov; 169(9):4961-9. PubMed ID: 12391209
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Long-term immunity against actual poxviral HLA ligands as identified by differential stable isotope labeling.
    Meyer VS; Kastenmuller W; Gasteiger G; Franz-Wachtel M; Lamkemeyer T; Rammensee HG; Stevanovic S; Sigurdardottir D; Drexler I
    J Immunol; 2008 Nov; 181(9):6371-83. PubMed ID: 18941228
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Invariant chain as a vehicle to load antigenic peptides on human MHC class I for cytotoxic T-cell activation.
    Wälchli S; Kumari S; Fallang LE; Sand KM; Yang W; Landsverk OJ; Bakke O; Olweus J; Gregers TF
    Eur J Immunol; 2014 Mar; 44(3):774-84. PubMed ID: 24293164
    [TBL] [Abstract][Full Text] [Related]  

  • 46. CD8+ T cells are necessary for recognition of allelic, but not locus-mismatched or xeno-, HLA class I transplantation antigens.
    Borenstein SH; Graham J; Zhang XL; Chamberlain JW
    J Immunol; 2000 Sep; 165(5):2341-53. PubMed ID: 10946256
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immunization with a peptide containing MHC class I and II epitopes derived from the tumor antigen SIM2 induces an effective CD4 and CD8 T-cell response.
    Kissick HT; Sanda MG; Dunn LK; Arredouani MS
    PLoS One; 2014; 9(4):e93231. PubMed ID: 24690990
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Human cytomegalovirus pp65- and immediate early 1 antigen-specific HLA class I-restricted cytotoxic T cell responses induced by cross-presentation of viral antigens.
    Tabi Z; Moutaftsi M; Borysiewicz LK
    J Immunol; 2001 May; 166(9):5695-703. PubMed ID: 11313411
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Efficiency and mechanism of antigen-specific CD8+ T-cell activation using synthetic long peptides.
    Zandvliet ML; Kester MG; van Liempt E; de Ru AH; van Veelen PA; Griffioen M; Guchelaar HJ; Falkenburg JH; Meij P
    J Immunother; 2012; 35(2):142-53. PubMed ID: 22306902
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Allogeneic GM-CSF-secreting tumor cell immunotherapies generate potent anti-tumor responses comparable to autologous tumor cell immunotherapies.
    Li B; Simmons A; Du T; Lin C; Moskalenko M; Gonzalez-Edick M; VanRoey M; Jooss K
    Clin Immunol; 2009 Nov; 133(2):184-97. PubMed ID: 19664962
    [TBL] [Abstract][Full Text] [Related]  

  • 51. EBV BILF1 evolved to downregulate cell surface display of a wide range of HLA class I molecules through their cytoplasmic tail.
    Griffin BD; Gram AM; Mulder A; Van Leeuwen D; Claas FH; Wang F; Ressing ME; Wiertz E
    J Immunol; 2013 Feb; 190(4):1672-84. PubMed ID: 23315076
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Alloreactive CD4+ and CD8+ T cells express the immunotolerant HLA-G molecule in mixed lymphocyte reactions: in vivo implications in transplanted patients.
    Le Rond S; Le Maoult J; Créput C; Menier C; Deschamps M; Le Friec G; Amiot L; Durrbach A; Dausset J; Carosella ED; Rouas-Freiss N
    Eur J Immunol; 2004 Mar; 34(3):649-660. PubMed ID: 14991594
    [TBL] [Abstract][Full Text] [Related]  

  • 53. HLA class I antigen processing machinery defects in antitumor immunity and immunotherapy.
    Maggs L; Sadagopan A; Moghaddam AS; Ferrone S
    Trends Cancer; 2021 Dec; 7(12):1089-1101. PubMed ID: 34489208
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Analyzing the effect of peptide-HLA-binding ability on the immunogenicity of potential CD8+ and CD4+ T cell epitopes in a large dataset.
    Wang S; Li J; Chen X; Wang L; Liu W; Wu Y
    Immunol Res; 2016 Aug; 64(4):908-18. PubMed ID: 27094547
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Microenvironmental stresses induce HLA-E/Qa-1 surface expression and thereby reduce CD8(+) T-cell recognition of stressed cells.
    Sasaki T; Kanaseki T; Shionoya Y; Tokita S; Miyamoto S; Saka E; Kochin V; Takasawa A; Hirohashi Y; Tamura Y; Miyazaki A; Torigoe T; Hiratsuka H; Sato N
    Eur J Immunol; 2016 Apr; 46(4):929-40. PubMed ID: 26711740
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Molecular mechanisms of HLA class I antigen abnormalities following viral infection and transformation.
    Seliger B; Ritz U; Ferrone S
    Int J Cancer; 2006 Jan; 118(1):129-38. PubMed ID: 16003759
    [TBL] [Abstract][Full Text] [Related]  

  • 57. HCMV glycoprotein US6 mediated inhibition of TAP does not affect HLA-E dependent protection of K-562 cells from NK cell lysis.
    Ulbrecht M; Hofmeister V; Yüksekdag G; Ellwart JW; Hengel H; Momburg F; Martinozzi S; Reboul M; Pla M; Weiss EH
    Hum Immunol; 2003 Feb; 64(2):231-7. PubMed ID: 12559625
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Adenovirus expressing β2-microglobulin recovers HLA class I expression and antitumor immunity by increasing T-cell recognition.
    Del Campo AB; Carretero J; Muñoz JA; Zinchenko S; Ruiz-Cabello F; González-Aseguinolaza G; Garrido F; Aptsiauri N
    Cancer Gene Ther; 2014 Aug; 21(8):317-32. PubMed ID: 24971583
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The Missing Link in Epstein-Barr Virus Immune Evasion: the BDLF3 Gene Induces Ubiquitination and Downregulation of Major Histocompatibility Complex Class I (MHC-I) and MHC-II.
    Quinn LL; Williams LR; White C; Forrest C; Zuo J; Rowe M
    J Virol; 2016 Jan; 90(1):356-67. PubMed ID: 26468525
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Novel insights into the molecular mechanisms of HLA class I abnormalities.
    Seliger B
    Cancer Immunol Immunother; 2012 Feb; 61(2):249-254. PubMed ID: 22120755
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.